Claims for Patent: 9,504,647

Summary for Patent: 9,504,647

Title:	Pharmaceutical formulations of desmopressin
Abstract:	Good bioavailability of desmopressin can be obtained by means of an orodispersible pharmaceutical dosage form. Preferred dosage forms comprise desmopressin and an open matrix network which is an inert water-soluble or water-dispersible carrier material. Desmopressin formulated in this way is useful for voiding postponement, or the treatment or prevention of incontinence, primary noctural enuresis (PNE), nocturia or central diabetes insipidus. Peptides other than desmopressin can also be formulated in this way.
Inventor(s):	Nilsson; Anders (Lund, SE), Lindner; Hans (Berlin, DE), Wittendorff; Jorgen (Hvidovre, DK)
Assignee:	FERRING B.V. (Hoofddorp, NL)
Application Number:	14/947,261
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,504,647
Patent Claims:	1. A solid orodispersible pharmaceutical dosage form of desmopressin acetate, comprising desmopressin acetate in an open matrix network carrying the desmopressin acetate, wherein the open matrix network comprises a water-soluble or water-dispersible carrier material inert to the desmopressin acetate that comprises gelatin, and wherein the dosage form disintegrates in the mouth within 10 seconds. 2. The dosage form of clam 1, wherein the gelatin comprises fish gelatin. 3. The dosage form of claim 1, wherein the gelatin comprises non-gelling fish gelatin. 4. The dosage form of claim 1, obtained by a process comprising sublimation of solvent from a composition comprising desmopressin acetate and a solution of the gelatin carrier material in a solvent. 5. The dosage form of claim 4, wherein the sublimation is carried out by freeze-drying the composition comprising desmopressin acetate and a solution of the gelatin carrier material in a solvent. 6. The dosage form of claim 4, wherein the composition is subject to sublimation in a mold. 7. The dosage form of claim 4, wherein the solvent is water. 8. The dosage form of claim 4, wherein the solution has a pH of from 3to 6. 9. A blister pack comprising a solid orodispersible pharmaceutical dosage form of claim 1. 10. A process for preparing a solid orodispersible pharmaceutical dosage form of desmopressin acetate which disintegrates in the mouth within 10 seconds, comprising sublimating solvent from a composition comprising desmopressin acetate and a solution of a water-soluble or water-dispersible carrier material inert to the desmopressin acetate that comprises gelatin in a solvent. 11. The process of clam 10, wherein the gelatin comprises fish gelatin. 12. The dosage form of claim 10, wherein the gelatin comprises non-gelling fish gelatin. 13. The process of claim 10, wherein the subliming is carried out by freeze-drying a composition comprising desmopressin acetate and a solution of the gelatin carrier material in a solvent. 14. The process of claim 10, wherein the composition is subject to the subliming in a mold. 15. The process of claim 10, wherein the solvent is water. 16. The process of claim 10, wherein the pH of the solution is from 3 to 6. 17. A method of administering desmopressin acetate to a subject in need thereof, comprising administering the solid orodispersible pharmaceutical dosage form of claim 1 to the subject. 18. The method of clam 17, wherein the subject is in need of voiding postponement and/or the treatment of incontinence, primary nocturnal enuresis (PNE), nocturia, and/or central diabetes insipidus.